| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | TGFB1 | Synonyms | CED, DPD1, IBDIMDE, LAP, TGF-beta1, TGFB, TGFbeta | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | transforming growth factor beta 1 | ||||
| GTO ID | GTC3531 |
| Trial ID | NCT05976555 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA|TGFB |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA-TGFβ CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I Study of BCMA-TGF-BETA Insensitive Armored CAR T Cells in Patients With Relapsed and/or Refractory Multiple Myeloma |
| Year | 2024 |
| Country | United States |
| Company sponsor | Medical College of Wisconsin |
| Other ID(s) | IIT-DHAKAL-TGF-BETA-BCMA |
| Cohort 1 | |||||||||
|
|||||||||